← Back to catalogue

Atlas Combo Board

FDA UDI

Class II (US FDA UDI)

by Neuralynx, Inc.

Identity

Trade Name
ATLAS COMBO BOARD FDA UDI
Generic Name
Electroencephalographic monitoring system FDA UDI
Device Name
The ATLAS Combo Board combines the functionality of the ATLAS Hybrid Input Board and ATLAS DRS-36 Board onto a single board, meaning the Digital Reference Selection and Analog to Digital Conversion for 32 electrodes is combined into a single slot. FDA UDI
Model / Reference
ATLAS COMBO BOARD FDA UDI
Description
The ATLAS Combo Board combines the functionality of the ATLAS Hybrid Input Board and ATLAS DRS-36 Board onto a single board, meaning the Digital Reference Selection and Analog to Digital Conversion for 32 electrodes is combined into a single slot. FDA UDI

Identifiers

Catalog Number
31-0605-0117 FDA UDI
Primary DI / UDI-DI
00850011306147 FDA UDI
510(k) Number
K110967 FDA UDI
FDA Product Code
OMC FDA UDI
GMDN Term
Electroencephalographic monitoring system FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.1400 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Electroencephalographic monitoring system

Atlas Combo Board by Neuralynx, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Electroencephalographic monitoring system.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Neuralynx, Inc.

Sources (1)

  • FDA UDI f18a0497-1704-40ce-9ad6-08c17c62d113 36 fields · synced May 29, 2026